|
Volumn , Issue 16, 1994, Pages 101-112
|
Late effects of adjuvant therapy for breast cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TAMOXIFEN;
ACUTE NONLYMPHOCYTIC LEUKEMIA;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
BREAST TUMOR;
CARDIOMYOPATHY;
CASE CONTROL STUDY;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
ENDOMETRIUM TUMOR;
FEMALE;
HUMAN;
INCIDENCE;
LEUKEMIA;
LYMPH NODE METASTASIS;
META ANALYSIS;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PREMATURE OVARIAN FAILURE;
RADIATION INJURY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SARCOMA;
SECOND CANCER;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARDIOMYOPATHIES;
CASE-CONTROL STUDIES;
CHEMOTHERAPY, ADJUVANT;
COHORT STUDIES;
COMBINED MODALITY THERAPY;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
INCIDENCE;
LEUKEMIA, NONLYMPHOCYTIC, ACUTE;
LEUKEMIA, RADIATION-INDUCED;
LYMPHATIC METASTASIS;
META-ANALYSIS;
MIDDLE AGED;
MULTICENTER STUDIES;
NEOPLASMS, RADIATION-INDUCED;
NEOPLASMS, SECOND PRIMARY;
OVARIAN FAILURE, PREMATURE;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
SARCOMA;
TAMOXIFEN;
TREATMENT OUTCOME;
|
EID: 0028711069
PISSN: 10526773
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (51)
|
References (142)
|